<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02812498</url>
  </required_header>
  <id_info>
    <org_study_id>535-B-102014</org_study_id>
    <nct_id>NCT02812498</nct_id>
  </id_info>
  <brief_title>Teleconsultation in Type 1 Diabetes Mellitus</brief_title>
  <acronym>TELEDIAB</acronym>
  <official_title>Teleconsultation in Type 1 Diabetes Mellitus</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Niguarda Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Niguarda Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the effects on glycemic control of Teleconsultation
      versus standard visit in outpatient clinic for patients affected by type 1 diabetes mellitus.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The growing incidence of diabetes and the need to contain health care costs empower the
      necessity to identify new models to cope with regular periodic follow up of patients affected
      by diabetes mellitus. Telemedicine offers an acknowledged instrument to provide clinical
      health care at a distance, increasing patient compliance and the achievement of therapeutical
      goals. This study wants to verify the feasibility and the efficacy of teleconsultation in
      patients with type 1 diabetes mellitus. In particular by a randomized controlled approach the
      effects on glycemic control of patients followed by teleconsultation or traditionally in
      standard visit in the outpatient clinic. The patients in the teleconsultation group will
      arrange their bookings on a website (http://www.telediabete-fid.it/) In this website they
      could also access to web educational courses (mainly nutrition, insulin management, glucose
      monitoring auto-control) or to nutritional and psychological counselling.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2015</start_date>
  <completion_date type="Actual">September 2018</completion_date>
  <primary_completion_date type="Actual">July 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>glycosylated hemoglobin HbA1c</measure>
    <time_frame>12th month</time_frame>
    <description>HbA1c is the main parameter representing the overall glycemic control. HbA1c can be assessed on three month bases but the value at 12 month is more representative of a sustained effect of this new approach</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>HbA1c glycosylated hemoglobin</measure>
    <time_frame>3rd to 6th to 9th month</time_frame>
    <description>changes of HbA1c glycosylated hemoglobin values</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfactory assessment by a questionnaire on their perception of advantages (diabetes management, comfort and convenience) and limits (technical problems, poor interaction with physicians) of the service</measure>
    <time_frame>12th month</time_frame>
    <description>A score of 1 (low) to 5 (High) will be used</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cost analysis by patient estimation through a questionnaire of the overall cost and time saved thanks to the service</measure>
    <time_frame>12th month</time_frame>
    <description>The average amount of cost and time saved will be calculated</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">150</enrollment>
  <condition>Type 1 Diabetes Mellitus</condition>
  <arm_group>
    <arm_group_label>Teleconsultation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Teleconsultation for patients affected by type 1 diabetes mellitus</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard visit in outpatient clinic for the same type of patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Teleconsultation</intervention_name>
    <description>The patients in the consultation group arranged their bookings on a website, where they could also access to web educational courses or to nutritional and psychological counselling</description>
    <arm_group_label>Teleconsultation</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard</intervention_name>
    <description>Group of patients followed in a traditional way</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients affected by type 1 diabetes mellitus, 5-50 years old under multi injection
             insulin therapy or under continuous subcutaneous insulin infusion

          -  with a feasible web access

        Exclusion Criteria:

          -  without a feasible web access

          -  that need a periodic physical examination
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>5 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>AO Ospedale Civile Legnano Legnano</name>
      <address>
        <city>Legnano</city>
        <zip>20025</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>ASST Grande Ospedale Metropolitano Niguarda</name>
      <address>
        <city>Milano</city>
        <zip>20162</zip>
        <country>Italy</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <reference>
    <citation>Bertuzzi F, Stefani I, Rivolta B, Pintaudi B, Meneghini E, Luzi L, Mazzone A. Teleconsultation in type 1 diabetes mellitus (TELEDIABE). Acta Diabetol. 2018 Feb;55(2):185-192. doi: 10.1007/s00592-017-1084-9. Epub 2017 Dec 5.</citation>
    <PMID>29209814</PMID>
  </reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>June 16, 2016</study_first_submitted>
  <study_first_submitted_qc>June 23, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 24, 2016</study_first_posted>
  <last_update_submitted>March 13, 2019</last_update_submitted>
  <last_update_submitted_qc>March 13, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>teleconsultation</keyword>
  <keyword>insulin therapy</keyword>
  <keyword>HbA1c</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
    <mesh_term>Diabetes Mellitus, Type 1</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

